A Y chromosome-linked factor impairs NK T development

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 3480-3487

  Wesley, Johnna D ^a   Tessmer, Marlowe S ^a   Paget, Christophe ^b   Trottein, François ^b   Brossay, Laurent ^a  

^a BROWN UNIVERSITY   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; ALPHA BETA INTERFERON RECEPTOR; CD1 ANTIGEN; GROWTH INHIBITOR; INTERFERON; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SPLEEN CELL; THYMUS; Y CHROMOSOME LINKAGE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CROSS BREEDING; GENETIC LINKAGE; GENETICS; IMMUNOLOGY; LYMPHOCYTOPENIA; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; Y CHROMOSOME;

ANIMALS; ANTIGENS, CD1; CELL DIFFERENTIATION; CROSSES, GENETIC; FEMALE; GROWTH INHIBITORS; INTERFERON TYPE I; KILLER CELLS, NATURAL; LINKAGE (GENETICS); LYMPHOPENIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; Y CHROMOSOME;

EID: 35748935861     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.3480     Document Type: Article

References (57)

1. Kronenberg, M., and I. Engel. 2007. On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr. Opin. Immunol. 19: 186-193.
2. Bendelac, A., P. B. Savage, and L. Teyton. 2006. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
3. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2: 557-568.
4. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
5. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
6. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
7. Sriram, V., W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35: 1692-1701.
8. Kinjo, Y., E. Tupin, D. Wu, M. Fujio, R. Garcia-Navarro, M. R. Benhnia, D. M. Zajonc, G. Ben-Menachem, G. D. Ainge, G. F. Painter, et al. 2006. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7: 978-986.
9. Tsuji, M. 2006. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell Mol. Life Sci. 63: 1889-1898.
10. Savage, P. B., L. Teyton, and A. Bendelac. 2006. Glycolipids for natural killer T cells. Chem. Soc. Rev. 35: 771-779.
11. + natural killer-T cell development. Eur. J. Immunol. 29: 3313-3318.
12. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.
13. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971-978.
14. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716.
15. - T cells in mice and humans. J. Exp. Med. 180: 1097-1106.
16. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCRα chain. J. Exp. Med. 178: 1-16.
17. Schumann, J., R. B. Voyle, B. Y. Wei, and H. R. MacDonald. 2003. Cutting edge: influence of the TCR Vα domain on the avidity of CD1d:β-galactosylceramide binding by invariant Vα14 NKT cells. J. Immunol. 170: 5815-5819.
18. Wei, D. G., S. A. Curran, P. B. Savage, L. Teyton, and A. Bendelac. 2006. Mechanisms imposing the Vβ bias of Vα14 natural killer T cells and consequences for microbial glycolipid recognition. J. Exp. Med. 203: 1197-1207.
19. Sidobre, S., O. V. Naidenko, B. C. Sim, N. R. Gascoigne, K. C. Garcia, and M. Kronenberg. 2002. The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169: 1340-1348.
20. + CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
21. Cantu, C., III, K. Benlagha, P. B. Savage, A. Bendelac, and L. Teyton. 2003. The paradox of immune molecular recognition of α-galactosylceramide: low affinity, low specificity for CD1d, high affinity for αβ TCRs. J. Immunol. 170: 4673-4682.
22. Porubsky, S., A. O. Speak, B. Luckow, V. Cerundolo, F. M. Platt, and H. J. Grone. 2007. From the cover: normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 104: 5977-5982.
23. Speak, A. O., M. Salio, D. C. Neville, J. Fontaine, D. A. Priestman, N. Platt, T. Heare, T. D. Butters, R. A. Dwek, F. Trottein, et al. 2007. From the cover: implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104: 5971-5976.
24. Bendelac, A., P. Matzinger, R. A. Seder, W. E. Paul, and R. H. Schwartz. 1992. Activation events during thymic selection. J. Exp. Med. 175: 731-742.
25. Benlagha, K., D. G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202: 485-492.
26. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of Vα14i NKT cells. Nat. Immunol. 3: 966-974.
27. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076.
28. Kronenberg, M. 2004. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
29. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189: 521-530.
30. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
31. Aichele, P., H. Unsoeld, M. Koschella, O. Schweier, U. Kalinke, and S. Vucikuja. 2006. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176: 4525-4529.
32. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
33. Karaghiosoff, M., H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, B. McCoy, C. Bogdan, T. Decker, G. Brem, et al. 2000. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13: 549-560.
34. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
35. Elewaut, D., L. Brossay, S. M. Santee, O. V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C. F. Ware, H. Cheroutre, and M. Kronenberg. 2000. Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. J. Immunol. 165: 671-679.
36. Robbins, S. H., M. S. Tessmer, T. Mikayama, and L. Brossay. 2004. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173: 259-266.
37. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
38. Malmgaard, L., T. P. Salazar-Mather, C. A. Lewis, and C. A. Biron. 2002. Promotion of α/β interferon induction during in vivo viral infection through α/β interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76: 4520-4525.
39. Zimmermann, A., M. Trilling, M. Wagner, M. Wilborn, I. Bubic, S. Jonjic, U. Koszinowski, and H. Hengel. 2005. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-γ signaling and antiviral responses. J. Exp. Med. 201: 1543-1553.
40. Bendelac, A. 2006. Innate-like lymphocytes. Curr. Opin. Immunol. 18: 517-518.
41. Matsuda, J. L., and L. Gapin. 2005. Developmental program of mouse Vα14i NKT cells. Curr. Opin. Immunol. 17: 122-130.
42. Elewaut, D., and M. Kronenberg. 2000. Molecular biology of NK T cell specificity and development. Semin. Immunol. 12: 561-568.
43. Berzins, S. P., A. P. Uldrich, D. G. Pellicci, F. McNab, Y. Hayakawa, M. J. Smyth, and D. I. Godfrey. 2004. Parallels and distinctions between T and NKT cell development in the thymus. Immunol. Cell Biol. 82: 269-275.
44. Eberl, G., B. Lowin-Kropf, and H. R. MacDonald. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163: 4091-4094.
45. Gadue, P., N. Morton, and P. L. Stein. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190: 1189-1196.
46. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20: 477-494.
47. Kim, P. J., S. Y. Pai, M. Brigl, G. S. Besra, J. Gumperz, and I. C. Ho. 2006. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177: 6650-6659.
48. Sagiv, Y., K. Hudspeth, J. Mattner, N. Schrantz, R. K. Stern, D. Zhou, P. B. Savage, L. Teyton, and A. Bendelac. 2006. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J. Immunol. 177: 26-30.
49. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, and J. P. Di Santo. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100: 2663-2668.
50. McNab, F. W., S. P. Berzins, D. G. Pellicci, K. Kyparissoudis, K. Field, M. J. Smyth, and D. I. Godfrey. 2005. The influence of CD1d in postselection NKT cell maturation and homeostasis. J. Immunol. 175: 3762-3768.
51. Yellayi, S., C. Teuscher, J. A. Woods, T. H. Welsh, Jr., K. S. Tung, M. Nakai, C. S. Rosenfeld, D. B. Lubahn, and P. S. Cooke. 2000. Normal development of thymus in male and female mice requires estrogen/estrogen receptor-α signaling pathway. Endocrine 12: 207-213.
52. McMurray, R. W., J. G. Wilson, L. Bigler, L. Xiang, and A. Lagoo. 2000. Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis. Int. J. Immunopharmacol. 22: 955-965.
53. Bouman, A., M. J. Heineman, and M. M. Faas. 2005. Sex hormones and the immune response in humans. Hum. Reprod. Update 11: 411-423.
54. Pasquier, B., L. Yin, M. C. Fondaneche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201: 695-701.
55. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons, S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11: 340-345.
56. Chung, B., A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan. 2005. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174: 3153-3157.
57. Rigaud, S., M. C. Fondaneche, N. Lambert, B. Pasquier, V. Mateo, P. Soulas, L. Galicier, F. Le Deist, F. Rieux-Laucat, P. Revy, et al. 2006. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444: 110-114.